Advertisement

Index by author

October 01, 1992; Volume 263,Issue 1

A

  1. Aberg, G

    1. Gastroprotective effects of thromboxane receptor antagonists.
      M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;

  2. Ahmad, S

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

  3. al-Kharouf, J A

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  4. Albrightson, C R

    1. Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
      C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

  5. Arrang, J M

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

B

  1. Bahl, J J

    1. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
      G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;

  2. Baraban, J M

    1. Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies.
      R V Bhat, A J Cole and J M Baraban
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 343-349;

  3. Beck, S G

    1. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
      S G Beck, K C Choi and T J List
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 350-359;

  4. Berger, M E

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  5. Berson, A

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

  6. Bhat, R V

    1. Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies.
      R V Bhat, A J Cole and J M Baraban
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 343-349;

  7. Bidlack, J M

    1. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
      D E Selley and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 99-104;

  8. Blandina, P

    1. Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
      P Blandina, D Johnson, J Walcott and J Goldfarb
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;

  9. Bowen, W D

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;

  10. Brickman, A S

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  11. Brown, M L

    1. Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.
      B Tesfamariam, M L Brown and R A Cohen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 153-157;

  12. Buchanan, L V

    1. Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
      S W Kerr, L V Buchanan, S Bunting and W R Mathews
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;

  13. Bunting, S

    1. Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
      S W Kerr, L V Buchanan, S Bunting and W R Mathews
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;

C

  1. Callaway, C W

    1. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
      C W Callaway and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 318-326;

  2. Catravas, J D

    1. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
      N Marczin, U S Ryan and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 170-179;

  3. Chang, C T

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  4. Chen, F

    1. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
      Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;

  5. Chen, I W

    1. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
      J H Lin, I W Chen and J King
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 105-111;

  6. Cheng, H Y

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  7. Chiang, P K

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

  8. Choi, J J

    1. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
      J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;

  9. Choi, K C

    1. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
      S G Beck, K C Choi and T J List
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 350-359;

  10. Cohen, M L

    1. Serotonin-induced relaxation in canine coronary artery smooth muscle.
      D J Cushing and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 123-129;

  11. Cohen, R A

    1. Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.
      B Tesfamariam, M L Brown and R A Cohen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 153-157;

  12. Cole, A J

    1. Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies.
      R V Bhat, A J Cole and J M Baraban
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 343-349;

  13. Collins, A C

    1. Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
      N C De Fiebre, R J Marley, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;

  14. Cook, V A

    1. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
      J S Leeder, R J Riley, V A Cook and S P Spielberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;

  15. Corcoran, G B

    1. Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
      S D Ray, C L Sorge, L M Kamendulis and G B Corcoran
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;

  16. Coy, D H

    1. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
      T W Moody, J Staley, F Zia, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;

  17. Cushing, D J

    1. Serotonin-induced relaxation in canine coronary artery smooth muscle.
      D J Cushing and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 123-129;

D

  1. Daniel, E E

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

  2. Davis, L L

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  3. de Cheffoy de Courcelles, D

    1. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
      D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;

  4. De Fiebre, N C

    1. Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
      N C De Fiebre, R J Marley, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;

  5. de Loore, K

    1. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
      D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;

  6. Dessy, C

    1. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
      T Godfraind, C Dessy and S Salomone
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 112-122;

  7. De Vries, T J

    1. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

  8. Ding, X Z

    1. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
      X Z Ding and I Mocchetti
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 368-373;

  9. Dionne, C A

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  10. Durham, S K

    1. Gastroprotective effects of thromboxane receptor antagonists.
      M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;

  11. Dytko, G

    1. Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
      C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

E

  1. Ehlert, F J

    1. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
      M T Griffin and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 221-225;

  2. Eugene, D

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

F

  1. Fau, D

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

  2. Feuerstein, G

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  3. Feuerstein, R

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  4. Fisch, C

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

  5. Fleming, W W

    1. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
      J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;

  6. Follmer, C H

    1. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
      Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;

  7. Freyne, E

    1. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
      D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;

  8. Fromenty, B

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

  9. Fujimoto, J M

    1. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
      J Y Xu, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 246-252;

  10. Fujita, A

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

G

  1. Ganellin, C R

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

  2. Garbarg, M

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

  3. Garland, H O

    1. Gentamicin-induced hypercalciuria in the rat: assessment of nephron site involved.
      H O Garland, D J Phipps and E S Harpur
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 293-297;

  4. Gessner, G W

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  5. Geyer, M A

    1. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
      C W Callaway and M A Geyer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 318-326;

  6. Godfraind, T

    1. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
      T Godfraind, C Dessy and S Salomone
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 112-122;

  7. Goldfarb, J

    1. Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
      P Blandina, D Johnson, J Walcott and J Goldfarb
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;

  8. Goldman, S

    1. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
      G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;

  9. Golub, M S

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  10. Gordon, R K

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

  11. Griffin, M T

    1. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
      M T Griffin and F J Ehlert
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 221-225;

  12. Grizzle, M K

    1. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
      M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;

  13. Groom, T

    1. Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
      C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

  14. Gu, J L

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

H

  1. Hajj-Ali, A F

    1. Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
      A F Hajj-Ali and B G Zimmerman
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 158-162;

  2. Harpur, E S

    1. Gentamicin-induced hypercalciuria in the rat: assessment of nephron site involved.
      H O Garland, D J Phipps and E S Harpur
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 293-297;

  3. Hata, F

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

  4. Hayakawa, E

    1. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
      A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;

  5. Henderson, S J

    1. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
      S J Henderson and W E Lindup
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 54-60;

  6. Hisada, T

    1. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
      M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;

  7. Hoenicke, E M

    1. The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      E M Hoenicke, S A Vanecek and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 276-284;

  8. Hogenboom, F

    1. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

  9. Honda, K

    1. Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
      H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;

  10. Hori, M

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  11. Howell, R E

    1. Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism.
      R E Howell and P N Lanken
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 130-135;

  12. Hruby, V J

    1. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

  13. Hu, Z

    1. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
      Z Hu and P G Wells
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 334-342;

  14. Huang, G J

    1. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
      J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;

I

  1. Iguchi, M

    1. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
      M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;

  2. Im, H K

    1. Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
      Y Zhu, H K Im and W B Im
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 207-213;

  3. Im, W B

    1. Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
      Y Zhu, H K Im and W B Im
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 207-213;

  4. Inagaki, O

    1. Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
      H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;

J

  1. James, M K

    1. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
      M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;

  2. Janssen, P A

    1. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
      D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;

  3. Jarvis, M F

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  4. Jaye, M

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  5. Jensen, R T

    1. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
      T W Moody, J Staley, F Zia, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;

  6. Johnson, D

    1. Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
      P Blandina, D Johnson, J Walcott and J Goldfarb
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;

  7. Johnson, S M

    1. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
      J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;

K

  1. Kamendulis, L M

    1. Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
      S D Ray, C L Sorge, L M Kamendulis and G B Corcoran
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;

  2. Kato, Y

    1. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
      A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;

  3. Kerr, S W

    1. Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
      S W Kerr, L V Buchanan, S Bunting and W R Mathews
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;

  4. Kikkawa, Y

    1. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
      H Sakai, T Okamoto and Y Kikkawa
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 381-386;

  5. King, J

    1. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
      J H Lin, I W Chen and J King
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 105-111;

  6. Kishi, I

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

  7. Kong, J Q

    1. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
      J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;

  8. Kostka, P

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

  9. Kurachi, Y

    1. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
      M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;

  10. Kwan, C Y

    1. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
      P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;

L

  1. Lang, I M

    1. The role of adrenergic receptors in the initiation of vomiting and its gastrointestinal motor correlates.
      I M Lang and S K Sarna
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 395-403;

  2. Lanken, P N

    1. Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism.
      R E Howell and P N Lanken
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 130-135;

  3. Lee, V H

    1. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
      A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;

  4. Leeder, J S

    1. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
      J S Leeder, R J Riley, V A Cook and S P Spielberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;

  5. Leedham, J A

    1. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
      J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;

  6. Lefevre, R

    1. Effects of intrauterine position on the hepatic microsomal polysubstrate monooxygenase and cytosolic glutathione S-transferase activity, plasma sex steroids and relative organ weights in adult male and female Long-Evans rats.
      T van der Hoeven, R Lefevre and R Mankes
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 32-39;

  7. Ligneau, X

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

  8. Lin, J H

    1. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
      J H Lin, I W Chen and J King
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 105-111;

  9. Lindup, W E

    1. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
      S J Henderson and W E Lindup
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 54-60;

  10. List, T J

    1. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
      S G Beck, K C Choi and T J List
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 350-359;

  11. Lu, Y

    1. Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
      T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;

  12. Lysko, K A

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  13. Lysko, P G

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

M

  1. Malmberg, A B

    1. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.
      A B Malmberg and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 136-146;
    2. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
      A B Malmberg and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 264-275;

  2. Mankes, R

    1. Effects of intrauterine position on the hepatic microsomal polysubstrate monooxygenase and cytosolic glutathione S-transferase activity, plasma sex steroids and relative organ weights in adult male and female Long-Evans rats.
      T van der Hoeven, R Lefevre and R Mankes
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 32-39;

  3. Marczin, N

    1. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
      N Marczin, U S Ryan and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 170-179;

  4. Marley, R J

    1. Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
      N C De Fiebre, R J Marley, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;

  5. Martin, G E

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  6. Mathews, W R

    1. Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
      S W Kerr, L V Buchanan, S Bunting and W R Mathews
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;

  7. Matsuda, Y

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
      S Oda, T Sano, Y Morishita and Y Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;

  8. McArdle, J J

    1. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
      J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;

  9. McKenna, P J

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

  10. Meltzer, H Y

    1. The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
      B K Yamamoto and H Y Meltzer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 180-185;

  11. Mocchetti, I

    1. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
      X Z Ding and I Mocchetti
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 368-373;

  12. Moody, T W

    1. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
      T W Moody, J Staley, F Zia, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;

  13. Morel, E

    1. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
      G Perrault, E Morel, D J Sanger and B Zivkovic
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;

  14. Morishita, Y

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
      S Oda, T Sano, Y Morishita and Y Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;

  15. Morkin, E

    1. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
      G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;

  16. Mosberg, H I

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;

  17. Mulder, A H

    1. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

N

  1. Nakajima, T

    1. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
      M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;

  2. Nambi, P

    1. Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
      C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

  3. Nishiura, A

    1. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
      A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;

  4. Nyby, M D

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

O

  1. O'Keefe, E H

    1. Gastroprotective effects of thromboxane receptor antagonists.
      M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;

  2. Oda, S

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
      S Oda, T Sano, Y Morishita and Y Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;

  3. Ogletree, M L

    1. Gastroprotective effects of thromboxane receptor antagonists.
      M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;

  4. Okamoto, T

    1. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
      H Sakai, T Okamoto and Y Kikkawa
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 381-386;

  5. Owyang, C

    1. Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
      T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;

P

  1. Pennock, G D

    1. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
      G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;

  2. Perrault, G

    1. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
      G Perrault, E Morel, D J Sanger and B Zivkovic
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;

  3. Pessayre, D

    1. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
      D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;

  4. Peterson, V A

    1. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
      J S Strobl and V A Peterson
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 186-193;

  5. Phipps, D J

    1. Gentamicin-induced hypercalciuria in the rat: assessment of nephron site involved.
      H O Garland, D J Phipps and E S Harpur
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 293-297;

  6. Pittaluga, A

    1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
      A Pittaluga and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 327-333;

  7. Porreca, F

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;

  8. Portoghese, P S

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;
    2. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

R

  1. Raiteri, M

    1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
      A Pittaluga and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 327-333;

  2. Ravera, M W

    1. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
      M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;

  3. Ray, S D

    1. Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
      S D Ray, C L Sorge, L M Kamendulis and G B Corcoran
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;

  4. Raya, T E

    1. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
      G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;

  5. Riley, R J

    1. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
      J S Leeder, R J Riley, V A Cook and S P Spielberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;

  6. Rouleau, A

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

  7. Rubin, B

    1. Gastroprotective effects of thromboxane receptor antagonists.
      M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;

  8. Ryan, U S

    1. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
      N Marczin, U S Ryan and J D Catravas
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 170-179;

S

  1. Saeki, K

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

  2. Sakai, H

    1. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
      H Sakai, T Okamoto and Y Kikkawa
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 381-386;

  3. Salomone, S

    1. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
      T Godfraind, C Dessy and S Salomone
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 112-122;

  4. Sanger, D J

    1. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
      G Perrault, E Morel, D J Sanger and B Zivkovic
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;

  5. Sano, T

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
      S Oda, T Sano, Y Morishita and Y Matsuda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;

  6. Sarma, J S

    1. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
      Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;

  7. Sarna, S K

    1. The role of adrenergic receptors in the initiation of vomiting and its gastrointestinal motor correlates.
      I M Lang and S K Sarna
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 395-403;

  8. Schoffelmeer, A N

    1. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
      A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;

  9. Schuster, S V

    1. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
      M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;

  10. Schwartz, J C

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

  11. Selley, D E

    1. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
      D E Selley and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 99-104;

  12. Shaffer, J E

    1. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
      M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;

  13. Shafik, E

    1. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
      J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;

  14. Singh, B N

    1. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
      Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;

  15. Sorge, C L

    1. Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
      S D Ray, C L Sorge, L M Kamendulis and G B Corcoran
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;

  16. Spielberg, S P

    1. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
      J S Leeder, R J Riley, V A Cook and S P Spielberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;

  17. Staley, J

    1. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
      T W Moody, J Staley, F Zia, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;

  18. Strobl, J S

    1. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
      J S Strobl and V A Peterson
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 186-193;

  19. Sudoh, K

    1. Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
      H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;

  20. Sugimoto, T

    1. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
      M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;

  21. Sultana, M

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;

T

  1. Takahashi, T

    1. Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
      T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;

  2. Takanashi, M

    1. Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
      H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;

  3. Takemori, A E

    1. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
      F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;

  4. Takeuchi, T

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

  5. Taylor, D A

    1. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
      J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;

  6. Tesfamariam, B

    1. Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.
      B Tesfamariam, M L Brown and R A Cohen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 153-157;

  7. Tseng, L F

    1. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
      J Y Xu, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 246-252;

  8. Tsunoda, Y

    1. Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
      T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;

  9. Tuck, M L

    1. Flavonoid potentiation of contractile responses in rat blood vessels.
      M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;

  10. Tuong, M D

    1. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
      M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;

V

  1. van der Hoeven, T

    1. Effects of intrauterine position on the hepatic microsomal polysubstrate monooxygenase and cytosolic glutathione S-transferase activity, plasma sex steroids and relative organ weights in adult male and female Long-Evans rats.
      T van der Hoeven, R Lefevre and R Mankes
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 32-39;

  2. Vanecek, S A

    1. The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      E M Hoenicke, S A Vanecek and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 276-284;

  3. Vuong, A

    1. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
      M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;

W

  1. Walcott, J

    1. Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
      P Blandina, D Johnson, J Walcott and J Goldfarb
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;

  2. Wehner, J M

    1. Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
      N C De Fiebre, R J Marley, J M Wehner and A C Collins
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;

  3. Wells, P G

    1. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
      Z Hu and P G Wells
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 334-342;

  4. Wiley, J

    1. Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
      T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;

  5. Woods, J H

    1. The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
      E M Hoenicke, S A Vanecek and J H Woods
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 276-284;

  6. Wu, W H

    1. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
      J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;

X

  1. Xu, J Y

    1. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
      J Y Xu, J M Fujimoto and L F Tseng
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 246-252;

Y

  1. Yagasaki, O

    1. Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
      F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;

  2. Yaksh, T L

    1. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.
      A B Malmberg and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 136-146;
    2. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
      A B Malmberg and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 264-275;

  3. Yamamoto, A

    1. A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
      A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;

  4. Yamamoto, B K

    1. The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
      B K Yamamoto and H Y Meltzer
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 180-185;

  5. Yazawa, H

    1. Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
      H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;

  6. Yue, T L

    1. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
      T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;

Z

  1. Zabko-Potapovich, B

    1. Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
      C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

  2. Zhang, Z H

    1. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
      Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;

  3. Zhu, Y

    1. Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
      Y Zhu, H K Im and W B Im
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 207-213;

  4. Zia, F

    1. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
      T W Moody, J Staley, F Zia, D H Coy and R T Jensen
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;

  5. Zimmerman, B G

    1. Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
      A F Hajj-Ali and B G Zimmerman
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 158-162;

  6. Zivkovic, B

    1. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
      G Perrault, E Morel, D J Sanger and B Zivkovic
      Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;
Back to top

In this issue